Literature DB >> 8954172

Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells.

M L Panno1, M Salerno, V Pezzi, D Sisci, M Maggiolini, L Mauro, E G Morrone, S Andò.   

Abstract

In a long-term experiment MCF-7 cells showed an exponential proliferation rate in fetal calf serum while they become quiescent in growth-factor- and steroid-free serum. The mitogenic activity of this cell line was increased by oestradiol and insulin, exposure to both hormones showing a synergic effect. These mitogen-mediated effects are inhibited by genistein a phytoestrogen which, by itself at the doses used, did not affect either the basal proliferation rate or the total protein content. Immunoblotting and Scatchard analysis reveal respectively that insulin increases the oestrogen receptor (ER) content and its binding capacity. The presence of genistein decreases the ER content and completely abolishes the binding capacity of this protein. Insulin is able to increase progesterone receptor (PR) levels while, in the presence of genistein, the above-reported effect was completely abolished. On the basis of the latter data the authors suggest that insulin is able to affect the phosphorylation status of ER and PR, inducing functional changes in both proteins, although this was in the absence of their natural ligands. Indeed, the presence in the medium of a tyrosine kinase inhibitor such as genistein could substantially decrease both ER and PR levels in these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954172     DOI: 10.1007/bf01209122

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  11 in total

Review 1.  Reproductive and general metabolic effects of phytoestrogens in mammals.

Authors:  R S Kaldas; C L Hughes
Journal:  Reprod Toxicol       Date:  1989       Impact factor: 3.143

2.  Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity.

Authors:  G Freiss; H Rochefort; F Vignon
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

3.  Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro.

Authors:  S F Arnold; J D Obourn; H Jaffe; A C Notides
Journal:  Mol Endocrinol       Date:  1995-01

Review 4.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

5.  Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.

Authors:  B S Katzenellenbogen; M J Norman
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

6.  Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.

Authors:  E J van Zoelen; T M van Oostwaard; P T van der Saag; S W de Laat
Journal:  J Cell Physiol       Date:  1985-05       Impact factor: 6.384

7.  The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells.

Authors:  F Auricchio; M Di Domenico; A Migliaccio; G Castoria; A Bilancio
Journal:  Cell Growth Differ       Date:  1995-02

8.  Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins.

Authors:  K Shuai; A Ziemiecki; A F Wilks; A G Harpur; H B Sadowski; M Z Gilman; J E Darnell
Journal:  Nature       Date:  1993-12-09       Impact factor: 49.962

9.  Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.

Authors:  B van der Burg; G R Rutteman; M A Blankenstein; S W de Laat; E J van Zoelen
Journal:  J Cell Physiol       Date:  1988-01       Impact factor: 6.384

10.  Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women.

Authors:  D D Baird; D M Umbach; L Lansdell; C L Hughes; K D Setchell; C R Weinberg; A F Haney; A J Wilcox; J A Mclachlan
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

View more
  14 in total

1.  The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.

Authors:  Amin Esfahani; Cyril W C Kendall; Balachandran Bashyam; Michael C Archer; David J A Jenkins
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-10-07       Impact factor: 2.416

2.  Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.

Authors:  V Bartella; P Rizza; I Barone; D Zito; F Giordano; C Giordano; S Catalano; L Mauro; D Sisci; M L Panno; S A W Fuqua; S Andò
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

Review 3.  Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

Authors:  D Yee; A V Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

Review 4.  The role of endocrine insulin-like growth factor-I and insulin in breast cancer.

Authors:  Danielle Lann; Derek LeRoith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-22       Impact factor: 2.673

5.  Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.

Authors:  C Agnoli; F Berrino; C A Abagnato; P Muti; S Panico; P Crosignani; V Krogh
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-10       Impact factor: 4.222

6.  G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts.

Authors:  Maria Francesca Santolla; Rosamaria Lappano; Paola De Marco; Marco Pupo; Adele Vivacqua; Diego Sisci; Sergio Abonante; Domenico Iacopetta; Anna Rita Cappello; Vincenza Dolce; Marcello Maggiolini
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

Review 7.  Crosstalk between IGF1R and estrogen receptor signaling in breast cancer.

Authors:  Dedra H Fagan; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-12       Impact factor: 2.673

8.  GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts.

Authors:  Ernestina Marianna De Francesco; Tommaso Angelone; Teresa Pasqua; Marco Pupo; Maria Carmela Cerra; Marcello Maggiolini
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

9.  Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.

Authors:  Manale Karam; Ivan Bièche; Christine Legay; Sophie Vacher; Christian Auclair; Jean-Marc Ricort
Journal:  J Cell Mol Med       Date:  2014-10-07       Impact factor: 5.310

10.  LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.

Authors:  Kairit Tints; Madis Prink; Toomas Neuman; Kaia Palm
Journal:  Int J Mol Sci       Date:  2014-04-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.